In The News How Fractyl Labs is ‘reversing’ type 2 diabetes to reduce or eliminate insulin injections – Mass Device (May, 2021) Fractyl Raises $55 Million in Series E Financing to Advance Revita DMR for Type 2 Diabetes – Business Wire (Aug 2020) Disease Modifying Therapies for Type 2 Diabetes (T2D) Fractyl Health is pioneering…
In The News Venture Investors to Score Giant Win From $3.4 Billion Sale of Auris Health – WSJ (Feb 2019) Johnson & Johnson Announces Completion of Acquisition of Auris Health, Inc. – Johnson & Johnson (April 2019) Diagnostic, Therapeutic and Surgical Robotics Platform Auris Health was acquired by Johnson & Johnson in 2019 for a…
Cofounder: Daniel Saks In The News AppDirect Partners With Adobe to Offer Market-Leading Products, Automate and Streamline VIP Marketplace – Financial Post (May, 2021) New $185M Growth Investment Will Fuel AppDirect’s Global Expansion – Crunchbase (Sept 2020) New AppSmart Invest Program Provides Smart Funding to Business Owners Leading Digital Commerce Platform and the world’s largest…
Building the world’s leading endemic resilience platform. Adagio is developing best-in-class antibodies that can broadly neutralize targeted families of viruses. The company is currently targeting SARS-CoV-2, SARS-CoV-1 and additional potentially emergent coronaviruses. Adagio antibodies will match or exceed the potency and coverage of conventional SARS-CoV-2 antibody programs, and can be used as both therapeutic and…
Founder: Dr. Gerngross In The News Adimab Provides Year-End Update on 2020 Partnership Activities – MarketScreener (Feb 2021) Adimab Spinout Adagio Raises $50M for Coronavirus Antibody R&D – Xconomy (July 2020) Antibody Discovery and Optimization Platform Adimab is the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies. The Adimab…
